Trial
NCT01760304
Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
AstraZeneca
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Intervention
Budesonide / Formoterol
Why stopped
Sponsor decided to stop the study due to expiration of blinded placebo .
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14